Investors including Quadria Capital and Denmark-based pharmaceutical major Novo Nordisk are among those interested in a ...

Investors need to pay close attention to Catalent (CTLT) stock based on the movements in the options market lately.

Tempus AI stock reached an important technical milestone, seeing its Relative Strength (RS) Rating jump into the 80-plus ...

To remedy this issue and accommodate the increasing demand in the US, Catalent could play a crucial role for the company. In February 2024, investment firm Novo Holdings acquired CDMO Catalent, while ...

Catalent (CTLT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

The first notable agency action in 2024 is the FTC’s Second Request in Novo Holding’s proposed $16.5 billion acquisition of Catalent, a life sciences contract manufacturer. 1 The agency’s interest in ...

On Thursday, Catalent Inc (CTLT) stock saw a decline, ending the day at $60.4 which represents a decrease of $-0.32 or -0.53% from the prior close of $60.72. The stock opened at $60.7 and touched a ...

Catalent Inc (CTLT) stock saw a decline, ending the day at $60.7 which represents a decrease of $-0.26 or -0.43% from the prior close of $60.96. The stock opened at $60.6 and touched a low of $60.49 ...

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...

Aug 30 (Reuters) - Catalent (CTLT.N), opens new tab said on Friday it was unable to file its annual report with regulators on time as it requires additional time to complete "certain processes".